new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing

Merck will soon market new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing.

The new tabs come in two strengths...35 and 70 mg.

Patients taking 5 mg/d to prevent osteoporosis use the 35 mg tab.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote